NVDA

185.05

+0.05%↑

AVGO.US

352.32

+2.1%↑

ORCL

204.69

+2.97%↑

MU

345.69

+0.22%↑

CSCO

74

+0.14%↑

NVDA

185.05

+0.05%↑

AVGO.US

352.32

+2.1%↑

ORCL

204.69

+2.97%↑

MU

345.69

+0.22%↑

CSCO

74

+0.14%↑

NVDA

185.05

+0.05%↑

AVGO.US

352.32

+2.1%↑

ORCL

204.69

+2.97%↑

MU

345.69

+0.22%↑

CSCO

74

+0.14%↑

NVDA

185.05

+0.05%↑

AVGO.US

352.32

+2.1%↑

ORCL

204.69

+2.97%↑

MU

345.69

+0.22%↑

CSCO

74

+0.14%↑

NVDA

185.05

+0.05%↑

AVGO.US

352.32

+2.1%↑

ORCL

204.69

+2.97%↑

MU

345.69

+0.22%↑

CSCO

74

+0.14%↑

Search

Azenta Inc

Fechado

SetorTecnologia

37.35 -0.77

Visão Geral

Variação de preço das ações

24h

Atual

Mín

37.01

Máximo

37.95

Indicadores-chave

By Trading Economics

Rendimento

50M

51M

Vendas

15M

159M

P/E

Médio do Setor

67.453

73.655

Margem de lucro

31.944

Funcionários

3,000

EBITDA

2.7M

21M

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+11.55% upside

Dividendos

By Dow Jones

Próximos Ganhos

4 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

298M

1.6B

Abertura anterior

38.12

Fecho anterior

37.35

Sentimento de Notícias

By Acuity

50%

50%

166 / 403 Ranking em Technology

Azenta Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de jan. de 2026, 23:54 UTC

Conversa de Mercado

CBA Could Underperform Again in 2026 -- Market Talk

12 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

12 de jan. de 2026, 23:43 UTC

Conversa de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 de jan. de 2026, 23:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 de jan. de 2026, 21:56 UTC

Conversa de Mercado

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

12 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

12 de jan. de 2026, 21:18 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

12 de jan. de 2026, 21:18 UTC

Conversa de Mercado

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 de jan. de 2026, 20:54 UTC

Ganhos

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 de jan. de 2026, 20:48 UTC

Conversa de Mercado

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 de jan. de 2026, 20:33 UTC

Conversa de Mercado

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 de jan. de 2026, 20:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 de jan. de 2026, 20:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 de jan. de 2026, 19:39 UTC

Conversa de Mercado

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 de jan. de 2026, 19:36 UTC

Conversa de Mercado

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 de jan. de 2026, 19:36 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 de jan. de 2026, 19:33 UTC

Conversa de Mercado

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 de jan. de 2026, 19:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 de jan. de 2026, 19:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 de jan. de 2026, 18:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 de jan. de 2026, 18:20 UTC

Aquisições, Fusões, Aquisições de Empresas

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 de jan. de 2026, 18:19 UTC

Conversa de Mercado

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 de jan. de 2026, 18:16 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 de jan. de 2026, 18:09 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

12 de jan. de 2026, 18:09 UTC

Conversa de Mercado

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 de jan. de 2026, 18:01 UTC

Aquisições, Fusões, Aquisições de Empresas

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 de jan. de 2026, 18:00 UTC

Conversa de Mercado

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Comparação entre Pares

Variação de preço

Azenta Inc Previsão

Preço-alvo

By TipRanks

11.55% parte superior

Previsão para 12 meses

Média 41.83 USD  11.55%

Máximo 50 USD

Mínimo 31 USD

Com base em 6 analistas de Wall Street que oferecem metas de preço de 12 meses para Azenta Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

6 ratings

5

Comprar

1

Manter

0

Vender

Sentimento

By Acuity

166 / 403 Ranking em Tecnologia

Sentimento de Notícias

Neutral

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Abaixo da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Azenta Inc

Azenta, Inc. provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates through three reportable segments: Sample Management Solutions, Multiomics, and B Medical Systems. The Sample Management Solutions segment provides sample management products and solutions, including automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled rate thawing devices, as well as sample repository services. This segment also offers consultation services to clients throughout their experimental design and implementation processes. The Multiomics segment provides genomic and other sample analysis services comprising gene sequencing, synthesis editing, and related services. The B Medical Systems segment manufactures and distributes temperature-controlled storage and transportation solutions to governments, health institutions, and non-government organizations. The company was formerly known as Brooks Automation, Inc. and changed its name to Azenta, Inc. in December 2021. Azenta, Inc. was founded in 1978 and is headquartered in Burlington, Massachusetts.
help-icon Live chat